 LEXINGTON, Mass.--BUSINESS WIRE--Cyteir Therapeutics, Inc. Cyteir Nasdaq: CYT, a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, will host a conference call and live audio webcast on Wednesday, March 16, 2022 at 4:30 p.m. ET to discuss fourth quarter and full year 2022 financial and operational results. The live audio webcast can be accessed via the Investor Relations section of the Companys website at The a 